Literature DB >> 15550284

Pharmacologic management of relapse prevention in addictive disorders.

Mehmet Sofuoglu1, Thomas R Kosten.   

Abstract

Substance use disorders are an important public health problem associated with significant mortality and morbidity. Effective maintenance pharmacotherapies are available for tobacco, alcohol, and opioid use disorders. For optimum treatment response, these medications should be used in conjunction with behavioral interventions. For other drugs of abuse, especially for cocaine, medication development is an active area of research. Further research is needed to develop new pharmacotherapies for substance use disorders and establish clinical guidelines on how to use these medications most effectively.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15550284     DOI: 10.1016/j.psc.2004.06.002

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  9 in total

Review 1.  Cognitive enhancement as a treatment for drug addictions.

Authors:  Mehmet Sofuoglu; Elise E DeVito; Andrew J Waters; Kathleen M Carroll
Journal:  Neuropharmacology       Date:  2012-06-23       Impact factor: 5.250

Review 2.  Agonist replacement therapy for cocaine dependence: a translational review.

Authors:  Craig R Rush; William W Stoops
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

3.  Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance.

Authors:  Craig R Rush; William W Stoops; Joshua A Lile; Paul E A Glaser; Lon R Hays
Journal:  Psychopharmacology (Berl)       Date:  2010-11-12       Impact factor: 4.530

4.  Diminished nicotine withdrawal in adolescent rats: implications for vulnerability to addiction.

Authors:  Laura E O'Dell; Adie W Bruijnzeel; Ron T Smith; Loren H Parsons; Michele L Merves; Bruce A Goldberger; Heather N Richardson; George F Koob; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2006-04-06       Impact factor: 4.530

5.  Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy.

Authors:  Craig R Rush; William W Stoops; Lon R Hays
Journal:  Drug Alcohol Depend       Date:  2008-10-15       Impact factor: 4.492

6.  Cannabinoid Antagonist Drug Discrimination in Nonhuman Primates.

Authors:  Brian D Kangas; Ani S Zakarian; Kiran Vemuri; Shakiru O Alapafuja; Shan Jiang; Spyros P Nikas; Alexandros Makriyannis; Jack Bergman
Journal:  J Pharmacol Exp Ther       Date:  2019-10-22       Impact factor: 4.030

7.  Environmental living conditions introduced during forced abstinence alter cocaine-seeking behavior and Fos protein expression.

Authors:  K J Thiel; N S Pentkowski; N A Peartree; M R Painter; J L Neisewander
Journal:  Neuroscience       Date:  2010-10-08       Impact factor: 3.590

Review 8.  Serotonergic mechanisms in addiction-related memories.

Authors:  Bríd A Nic Dhonnchadha; Kathryn A Cunningham
Journal:  Behav Brain Res       Date:  2008-07-01       Impact factor: 3.332

Review 9.  Agonist replacement for stimulant dependence: a review of clinical research.

Authors:  William W Stoops; Craig R Rush
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.